Ivan Kushkevych (He/Him)

Associate Professor, Faculty of Medicine, Masaryk University
  • Czechia

About Ivan Kushkevych

A scientist in the field of microbiology who received his first scientific degree, Candidate of Biological Sciences (CSc) in Microbiology, in 2010 – equivalent to a Ph.D. degree. Subsequently, he was awarded the Doctor of Biological Sciences (DSc) degree in Microbiology in 2016.

In addition, Dr. Kushkevych earned a second Ph.D. degree in Pharmacology and Toxicology in 2021 (Faculty of Pharmacy at Masaryk University, Brno, Czech Republic). His Ph.D. thesis was entitled “Testing the cytotoxicity and biological effects of salicylamide derivatives against intestinal sulfate-reducing bacteria”. His research focuses on the physiological and biochemical characteristics of sulfate-reducing microorganisms and their functional role in the development of inflammatory bowel disease in humans and animals.

Dr. Kushkevych is the sole author of original books entitled "Intestinal Sulfate-Reducing Bacteria" (2017) and "Bacterial Physiology and Biochemistry" (2022) as well as the author of several chapters of other books, among them are “Sulfate source and its role in the development of colitis” in the book "Colitis: Causes, Diagnosis and Treatment", Nova Science Publishers, Inc., Hauppauge, New York, United States (2019); “Isolation and purification of sulfate-reducing bacteria” in the book "Microorganisms", IntechOpen, London, United Kingdom (2019); and “Effect of intestinal microbiome, antibiotics, and probiotics in the prevention and management of ulcerative colitis” in the book "Probiotics in the Prevention and Management of Human Diseases: A Scientific Perspective", Elsevier Academic Press (2022).

Dr. Kushkevych previously worked at the Department of Human Pharmacology and Toxicology at University of Veterinary and Pharmaceutical Sciences (Brno, Czech Republic) and currently works as an Associate Professor at Masaryk University in Brno, Czech Republic.

Dr. Kushkevych’s scientific interests include sulfate-reducing microorganisms, sulfate dissimilation, inflammatory bowel disease, ulcerative colitis, lactic acid bacteria, and phototrophic sulfur bacteria.

Popular Content

Online Elsewhere